I was sitting in the waiting room of Coastal Premier Insurance with my son’s medical file in my lap – when the woman behind the counter LAUGHED at the word “experimental.”
Donovan is six. He has been sick since he was four, and the treatment his doctor says could help him has been denied three times. Three times I drove to this office. Three times I sat in this same plastic chair.
I’m Priya. Single mom. I work two jobs and I have never missed a premium payment. Not once.
The first time they denied us, the letter said the treatment was “not medically necessary.” His oncologist had written four pages explaining why it was. I filed an appeal. Denied again.
Then I started paying attention.
The woman who processed our claims was named Debra Holt. I found her name on the second denial letter. I Googled her. Then I Googled the company she worked for before Coastal Premier.
It was a pharmaceutical company. One that made the cheaper drug they kept trying to push on Donovan instead.
A few days later I started recording my calls. Every single one. I have forty-seven recordings now.
Then I filed a public records request and got their internal denial rate for pediatric oncology claims.
Eighty-one percent.
I sat in my car outside this building and just stared at that number.
I reached out to a journalist at the state paper. She was very interested. She asked me to bring everything I had.
I brought it today.
I also brought a copy of Debra Holt’s LinkedIn profile, her old employment contract – which someone had accidentally attached to an internal email they sent me – and a spreadsheet I’d built over four months.
Debra called my name from behind the counter. Same flat voice. Same look.
“Ms. Anand, we’ve reviewed Donovan’s case again and the answer is still – “
“I know,” I said. “That’s why I brought her.”
The woman who stepped through the door behind me set her recorder on the counter and said, “Ms. Holt, I’m Karen Duff from the Tribune. I have some questions about your time at Vericel Pharma.”
What Debra Holt’s Face Did Next
I’ve thought about that moment a lot.
Not because it felt like a victory. I don’t know yet if it is one. But Debra Holt’s face did something I hadn’t seen it do in three visits and forty-seven phone calls.
It went blank. Completely blank. Like a computer screen when the power cuts.
She looked at Karen. Then at me. Then at the recorder sitting on the laminate counter between us. The recorder was small, gray, unremarkable. Karen had set it down gently, the way you’d set down a glass of water.
The waiting room had maybe eight other people in it. A man with a folder. A woman with a baby on her lap. A teenager staring at his phone. They all looked up.
Debra said, “I’m going to need to get my supervisor.”
“That’s fine,” Karen said. “We have time.”
I sat back down in the plastic chair. The same one. I put Donovan’s file back in my lap and I looked at the ceiling and I breathed.
How I Got Here
I should back up.
I’m not someone who does things like this. I’m not confrontational by nature. I grew up in a house where you said thank you to people even when they were wrong, where you didn’t make scenes, where you trusted that systems existed for a reason and that if you followed the rules the systems would follow them back.
Donovan’s diagnosis broke that assumption into pieces.
He was four years and three months old when his pediatrician found the mass. I remember the exact day: a Tuesday in February, cold enough that the parking lot still had ice at the edges. Dr. Mehta used very calm language and I remember thinking, while she spoke, that I needed to call my mother. That was the only thought my brain could produce. I need to call my mother.
The treatment protocol his oncologist, Dr. Rashida Okonkwo, recommended is called targeted immunotherapy. It’s not experimental in the sense of unproven. It’s been used in pediatric oncology for six years. Donovan’s specific tumor markers make him a strong candidate. Dr. Okonkwo wrote that in the letter. She wrote it again in the appeal. She wrote it a third time in a letter that was eleven pages long and included three peer-reviewed studies and the names of seven other children who’d responded well.
Coastal Premier denied it each time in letters that averaged one paragraph.
The first denial came on a Thursday. I read it standing at the kitchen counter while Donovan watched cartoons in the next room. I read it twice. I put it face-down on the counter and I went and sat next to him on the couch and watched twenty minutes of a show about a dog who solves mysteries.
Then I got up and filed the appeal.
The Thing About Debra Holt
I want to be careful here because I don’t know Debra Holt. I don’t know if she’s a bad person or just a person doing a job badly or a person doing a job the way the job was designed to be done.
What I know is her name was on the denial letters. What I know is that her LinkedIn said she spent eight years at Vericel Pharmaceuticals as a “managed care liaison,” which I eventually figured out means she was the person who talked to insurance companies about which drugs to favor. Vericel makes Korixin. Korixin is the drug Coastal Premier kept suggesting as an alternative to the immunotherapy Dr. Okonkwo recommended.
Korixin costs the insurer less. It also has a lower response rate in Donovan’s tumor subtype. Dr. Okonkwo told me this in words I wrote down verbatim: “For his markers, Korixin’s response rate is roughly half. I would not recommend it.”
I’m not saying Debra Holt is corrupt. I’m saying the structure she works inside has a shape, and that shape has a name on it, and her name is part of that shape.
The employment contract had been attached to an internal email by accident. Someone in their claims department had forwarded a chain to me while trying to send me a different document, and at the bottom of the chain was a scanned PDF of what appeared to be Debra Holt’s original hiring agreement with Coastal Premier, which included a non-compete clause specifically exempting Vericel Pharmaceuticals.
I read that three times.
Then I saved it in five different places.
The Spreadsheet
Four months of work. I want to explain what that looked like because I think people hear “spreadsheet” and imagine something tidy and corporate, some person in a good office with a second monitor.
I built it on my laptop at the kitchen table after Donovan went to sleep. Some nights that was 8:30. Some nights it was closer to 11 because he’d had a bad day and needed more. I’d pour whatever was left of the coffee from the morning, put in my earbuds, and work.
The public records request took six weeks to come back. When it did, it was 340 pages. I read all of them. I flagged 94. I cross-referenced claim IDs against denial reasons, against claim types, against the dates the denials were issued and who signed them.
Pediatric oncology claims: 81% denial rate.
Adult cardiac claims: 34%.
General surgical: 29%.
I am not a statistician. I’m a woman with a biology degree from a state school who works as a lab technician and picks up weekend shifts at a copy center. But I know what a pattern looks like.
Karen Duff, when I sent her the spreadsheet, wrote back in four minutes. Her email said: “Can we talk this week?”
We talked for two hours. She asked me to save everything, send nothing else to anyone, and come to the office in person before I did anything at Coastal Premier.
“I want to be there,” she said.
The Supervisor
His name was Gary Pruitt. I know because it said so on the lanyard he was still clipping on when he came through the door from the back.
He was maybe fifty. Tan jacket, reading glasses pushed up on his forehead. He looked at Karen’s recorder. He looked at Karen. He looked at me.
“Ms. Anand,” he said. “I understand you have some concerns about Donovan’s case.”
“She doesn’t just have concerns,” Karen said. “She has documentation. I’m going to be writing about it regardless of what happens in this room today. But I wanted to give your office a chance to comment.”
Gary Pruitt asked Karen who she worked for. She told him. He asked if she had press credentials. She showed him.
Then he looked at me again. Different look this time. Not the flat look Debra had. Something more like calculation.
“What is it you’re hoping to get out of today, Ms. Anand?”
I’d thought about this. I’d thought about it for four months, honestly, in the way you think about something while you’re doing dishes and while you’re driving and while you’re sitting in a hospital waiting room watching your son get bloodwork.
“I want Donovan’s treatment approved,” I said. “I want it approved this week. And I want to understand why eighty-one percent of pediatric oncology claims get denied at this company when the national average is closer to forty.”
He didn’t answer the second part.
He said he’d need to make some calls.
Karen said we’d wait.
The Plastic Chair
We sat there for an hour and forty minutes. Karen worked on her phone. I sat with Donovan’s file in my lap and tried not to think too hard about anything.
The waiting room cycled through people. The man with the folder. A woman in scrubs who looked exhausted. A couple who spoke quietly to each other in Portuguese and kept looking at a paper they’d brought.
I thought about all of them. I thought about whether any of them had gotten a denial letter. Whether any of them had sat in a car outside this building and stared at a number.
Probably some of them had.
Probably most of them had gone home and filed an appeal and been denied again and eventually stopped. Not because they didn’t care. Because they were tired. Because they had jobs and kids and other things that needed doing and at some point the system just grinds you down to a place where giving up feels like a rational choice.
I almost got there. January of this year, after the third denial, I sat in the parking lot of the copy center during my break and cried for about eight minutes and then genuinely considered whether I should just try the Korixin. Whether Dr. Okonkwo was wrong. Whether I was making this harder than it needed to be.
Then I went back inside and printed someone’s wedding invitations and went home and opened my laptop.
What Gary Pruitt Said When He Came Back
“We’ve completed an expedited review of Donovan’s file.”
He had a woman with him now. Younger, in a blazer, holding a folder. She didn’t introduce herself.
“Given the documentation provided by Dr. Okonkwo and the specifics of Donovan’s case, we’ve determined that the targeted immunotherapy treatment meets the criteria for medical necessity under his current plan.”
Karen’s recorder was still on the counter.
I said, “I need that in writing before I leave this building.”
The woman in the blazer said that could be arranged.
I said, “Today.”
She said yes.
I looked at Gary Pruitt. He wasn’t looking at me. He was looking at a spot somewhere above my left shoulder.
“And the eighty-one percent?” I said.
He said that was a matter they took seriously and would be reviewing internally.
Karen wrote something down.
I have no idea what happens to that number now. I have no idea if the Tribune story changes anything for anyone other than Donovan. I have no idea if Debra Holt’s conflict of interest goes anywhere or just gets buried in an internal review that nobody ever sees.
What I know is that I walked out of that building with a letter. Approval for treatment. Donovan starts in three weeks.
I called my mother from the parking lot. Same parking lot. Still cold, but different cold, the end-of-winter kind that has a little give in it.
She picked up on the second ring and I didn’t say anything for a second and she said, “Priya.”
“We got it,” I said.
She made a sound I don’t have a word for.
I sat in my car for a while after that. Not staring at any numbers. Just sitting.
—
If this story matters to you, pass it along. Someone else might be sitting in that same plastic chair right now.
If you’re looking for more stories about uncovering secrets and unexpected twists, you might enjoy reading about when my best friend called out sick, but I found out where he was really going, or the moment my husband texted “love you” while I was standing in his other family’s apartment.
